Glycorex Transplantation AB
Develops devices that remove blood antibodies, enabling organ transplants across blood groups.
GTAB | NGM
Overview
Corporate Details
- ISIN(s):
- SE0000524522 (+1 more)
- LEI:
- 549300BFHBYZ3X96EP25
- Country:
- Sweden
- Address:
- Scheelevägen 27, 223 63 Lund
- Website:
- https://glycorex.com/
- Sector:
- Manufacturing
- Industry:
- Manufacture of medical and dental instruments and supplies
Description
Glycorex Transplantation AB is a medical technology company that develops, produces, and sells medical devices for extracorporeal blood treatments. The company's core business is centered on its unique technology platform which uses biologically active carbohydrates to selectively remove specific antibodies from blood. Its flagship product, Glycosorb® ABO, enables organ and stem cell transplants across blood group barriers (ABO-incompatible). Used clinically since 2001, the device has facilitated thousands of successful kidney, liver, heart, and stem cell transplants globally. Building on its technology, Glycorex is expanding into new applications, including developing universal blood plasma for transfusion medicine and creating novel treatments for severe autoimmune diseases, with an initial focus on rheumatoid arthritis.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
Automate Your Workflow. Get a real-time feed of all Glycorex Transplantation AB filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Need More History? Access decades of standardized financials for Glycorex Transplantation AB via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
/other/Spermosens_AB_publ-logo.jpg){kind=logo}
